Sarcoidosis
📧 Sign up to get email alerts when something new happens for Sarcoidosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-04-29Clinical Trial Update: Tyrosine Kinase 2 (TYK2) for GA and CS [Phase 2]
A Phase 2 trial evaluating a TYK2-targeted therapy for sarcoidosis and granuloma annulare was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2020-11-20Clinical Trial Update: ACTHAR Therapy for Central Nervous System Sarcoidosis [Phase 4]
A Phase 4 clinical trial of ACTHAR Therapy for central nervous system sarcoidosis was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-11-06Clinical Trial Update: Study to Determine the Efficacy of Adalimumab in the Treatment of Cutaneous Sarcoidosis [Phase 2]
A Phase 2 study evaluating adalimumab for cutaneous sarcoidosis was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-07-13Clinical Trial Update: EBUS-TBNA Versus EBUS-TBNB [NA]
A clinical trial comparing EBUS-TBNA to EBUS-TBNB has been withdrawn from the registry, per the sponsor Royal Brompton & Harefield NHS Found…
-
CLINICAL_TRIALS withdrawal · 2015-06-25Clinical Trial Update: CryoSpray Ablation(tm)Thoracic Patient Registry
A thoracic patient registry evaluating CryoSpray Ablation has been withdrawn from the trial registry. The study covered conditions including…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2013-10-30Clinical Trial Update: Cardiac Sarcoidosis Response To Steroids Trial [Phase 4]
The Phase 4 clinical trial evaluating response to steroids in cardiac sarcoidosis has been withdrawn.